Standout Papers
- Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC) (2007)
- Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL) (2006)
- Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma (2007)
- Alopecia areata investigational assessment guidelines–Part II (2004)
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunity (2010)
Immediate Impact
8 by Nobel laureates 10 from Science/Nature 57 standout
Citing Papers
Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
2024 Standout
Works of Madeleine Duvic being referenced
T-cell lymphoma secondary to checkpoint inhibitor therapy
2020
Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Madeleine Duvic | 13980 | 8668 | 7743 | 620 | 25.5k | |
| Thomas Ruzicka | 11488 | 3088 | 6096 | 660 | 25.3k | |
| Mark R. Pittelkow | 5853 | 3965 | 3436 | 360 | 18.8k | |
| Martín C. Mihm | 7452 | 2826 | 8140 | 451 | 33.8k | |
| Oliver Distler | 4051 | 12114 | 5189 | 580 | 24.7k | |
| Brian J. Nickoloff | 5489 | 1697 | 8902 | 236 | 18.7k | |
| Lars E. French | 4968 | 2620 | 7212 | 471 | 20.6k | |
| Juliet N. Barker | 8700 | 2449 | 16763 | 539 | 30.3k | |
| Manabu Fujimoto | 2805 | 5619 | 6686 | 483 | 17.2k | |
| Reinhard Dummer | 8328 | 5803 | 14420 | 940 | 43.0k | |
| Enno Christophers | 5808 | 1362 | 9842 | 357 | 18.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...